1,644
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release

, , , , , , , , & show all
Pages 2820-2826 | Received 19 Aug 2015, Accepted 26 Sep 2015, Published online: 30 Oct 2015

References

  • Chang LC, Wu SC, Tsai JW, et al. (2009). Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery. Int J Pharm 376:195–203
  • Cima MJ, Lee H, Daniel K, et al. (2014). Single compartment drug delivery. J Control Release 190:157–71
  • Collado A, Chechile GE, Salvador J, Vicente J. (2000). Early complications of endoscopic treatment for superficial bladder tumors. J Urol 164:1529–32
  • Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. (2006). A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23:2709–28
  • Fraser MO, Chuang YC, Tyagi P, et al. (2003). Intravesical liposome administration – a novel treatment for hyperactive bladder in the rat. Urology 61:656–63
  • Guhasarkar S, Banerjee R. (2010). Intravesical drug delivery: challenges, current status, opportunities and novel strategies. J Control Release 148:147–59
  • Ilic-Stojanovic S, Nikolic L, Nikolic V, et al. (2012). Potential application of thermo-sensitive hydrogels for controlled release of phenacetin. Hem Ind 66:831–9
  • Ilic-Stojanovic S, Nikolic L, Nikolic V, et al. (2013). Synthesis and characterization of thermosensitive hydrogels and the investigation of modified release of ibuprofen. Hem Ind 67: 901–12
  • Krafft MP. (2001). Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv Drug Deliv Rev 47:209–28
  • Lin T, Zhang Y, Wu J, et al. (2014a). A floating hydrogel system capable of generating CO2 bubbles to diminish urinary obstruction after intravesical instillation. Pharm Res 31:2655–63
  • Lin TS, Wu JH, Zhao XZ, et al. (2014b). In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract. J Pharm Sci 103:927–36
  • Lu Z, Yeh TK, Tsai M, et al. (2004). Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res 10:7677–84
  • Men K, Liu W, Li L, et al. (2012). Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system. Nanoscale 4:6425–33
  • Rapoport N, Gao Z, Kennedy A. (2007). Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99:1095–106
  • Siegel R, Ma J, Zou Z, Jemal A. (2014). Cancer statistics, 2014. CA Cancer J Clin 64:9–29
  • Tyagi P, Chancellor MB, Li Z, et al. (2004a). Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes. J Urol 171:483–9
  • Tyagi P, Li ZH, Chancellor M, et al. (2004b). Sustained intravesical drug delivery using thermosensitive hydrogel. Pharm Res 21:832–7
  • Zhang D, Sun P, Li P, et al. (2013). A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette-Guerin in the treatment of bladder cancer. Biomaterials 34:10258–66
  • Zhang L, Parsons DL, Navarre C, Kompella UB. (2002). Development and in-vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur. J Control Release 85:73–81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.